Find Clinical Trials
Phase I/II study of oral administration of S 49076 given in combination with gefitinib in patients with EGFR mutated advanced non-small-cell lung cancer who have progressed after treatment with EGFR tyrosine kinase inhibitor.
Servier Protocol Code:
CL1-49076-003
Sponsor:
Institut de Recherches Internationales Servier (I.R.I.S)
EudraCT Number:
2015-002646-31
Find a recruiting site
Name:
Institut de Recherches Internationales Servier, Département des études cliniques
Phone number:
+33 1 55 72 60 00
Results
English (USA)Interventions / Treatments
The treatment(s) given to the participants in the study.
- Solid tumors
- S049076
Other study id numbers
Other identification numbers the study may be known by.
- CL1-49076-003